SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹11 Cr | ₹5.67 Cr | ₹2.75 Cr | ₹8.12 Cr | ₹7.01 Cr |
What is the latest Contingent Liabilities ratio of SMS PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹5.67 Cr |
| Mar2023 | ₹2.75 Cr |
| Mar2022 | ₹8.12 Cr |
| Mar2021 | ₹7.01 Cr |
How is Contingent Liabilities of SMS PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 94.02 | |
| Mar2024 | ₹5.67 Cr | 105.88 | |
| Mar2023 | ₹2.75 Cr | -66.09 | |
| Mar2022 | ₹8.12 Cr | 15.77 | |
| Mar2021 | ₹7.01 Cr | - | |
Compare Contingent Liabilities of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,406.0 Cr | -4.6% | -13.8% | 58% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -4.6% |
-13.8% |
58% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses